1. Home
  2. VLN vs FHTX Comparison

VLN vs FHTX Comparison

Compare VLN & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLN
  • FHTX
  • Stock Information
  • Founded
  • VLN 2006
  • FHTX 2015
  • Country
  • VLN Israel
  • FHTX United States
  • Employees
  • VLN N/A
  • FHTX N/A
  • Industry
  • VLN Semiconductors
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • VLN Technology
  • FHTX Health Care
  • Exchange
  • VLN Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • VLN 260.6M
  • FHTX 237.4M
  • IPO Year
  • VLN N/A
  • FHTX 2020
  • Fundamental
  • Price
  • VLN $2.45
  • FHTX $5.23
  • Analyst Decision
  • VLN Strong Buy
  • FHTX Strong Buy
  • Analyst Count
  • VLN 1
  • FHTX 6
  • Target Price
  • VLN $4.00
  • FHTX $13.17
  • AVG Volume (30 Days)
  • VLN 424.1K
  • FHTX 163.3K
  • Earning Date
  • VLN 02-26-2025
  • FHTX 03-06-2025
  • Dividend Yield
  • VLN N/A
  • FHTX N/A
  • EPS Growth
  • VLN N/A
  • FHTX N/A
  • EPS
  • VLN N/A
  • FHTX N/A
  • Revenue
  • VLN $63,134,000.00
  • FHTX $25,515,000.00
  • Revenue This Year
  • VLN N/A
  • FHTX N/A
  • Revenue Next Year
  • VLN $28.12
  • FHTX $8.30
  • P/E Ratio
  • VLN N/A
  • FHTX N/A
  • Revenue Growth
  • VLN N/A
  • FHTX N/A
  • 52 Week Low
  • VLN $1.67
  • FHTX $3.86
  • 52 Week High
  • VLN $3.50
  • FHTX $10.25
  • Technical
  • Relative Strength Index (RSI)
  • VLN 44.34
  • FHTX 52.39
  • Support Level
  • VLN $2.33
  • FHTX $3.89
  • Resistance Level
  • VLN $3.00
  • FHTX $6.27
  • Average True Range (ATR)
  • VLN 0.18
  • FHTX 0.59
  • MACD
  • VLN -0.01
  • FHTX 0.11
  • Stochastic Oscillator
  • VLN 28.57
  • FHTX 48.38

About VLN Valens Semiconductor Ltd.

Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: